IVAVIB 5 IVABRADINE 5mg. IP

Ivavib 5 (Ivabradine 5 mg) tablets lower hospitalisation risk in stable heart failure (LVEF≤35%, sinus rhythm, HR≥70) on maximal beta-blockers. Main uses: reduces the risk of hospitalisation for worsening heart failure; used in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction (LVEF) of 35% or less; used when the patient is in sinus rhythm with a resting heart rate of 70 beats per minute or more; used together with other heart failure treatment when beta-blockers are already given at maximally tolerated doses, or when beta-blockers cannot be used.

Common side effects of Ivavib 5 Tablet include slow heart rate (bradycardia); high blood pressure or raised blood pressure; atrial fibrillation (irregular heartbeat); phosphenes or luminous phenomena (brief flashes or brightness in vision); visual brightness. Get medical help at once if you notice atrial fibrillation; bradycardia and conduction disturbances (heart block); harm to the unborn baby if taken during pregnancy.

Each Ivavib 5 tablet contains Ivabradine 5 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Ivavib 5 Tablet only as your doctor advises.

The MRP of Ivavib 5 Tablet is ₹182.81 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹139.28 and the PTS is ₹125.36.

Each Ivavib 5 tablet contains Ivabradine 5 mg. It comes in a pack of 10x10 (Alu Alu).

The main ingredient works on the sinoatrial node, the natural pacemaker of the heart. It blocks the channel that carries the pacemaker current responsible for the resting heart rate, so the heart beats more slowly. Ivabradine acts mainly on this node and does not affect the force of the heart's pumping or its electrical recovery.

Must not be used in acute decompensated heart failure. Must not be used in patients with clinically significant hypotension (low blood pressure). Must not be used in sick sinus syndrome, sinoatrial block or third degree AV block unless a functioning demand pacemaker is present. Must not be used in clinically significant bradycardia, in severe hepatic impairment, when the heart rate is maintained only by a pacemaker, or with strong CYP3A4 inhibitors. Ivabradine may harm the unborn baby, so females of reproductive potential must use effective contraception; use is not recommended in second degree AV block; check with a doctor first in pregnancy or breastfeeding and about all other medicines being taken.

Ivavib 5 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.